Article

Obesity induced bronchopulmonary hyperresponsiveness in Tunisian women.

Clinical Laboratory of Physiology, Physiology and Functionnal Testing Department 99/UR 08-67, Medical School of Sousse, Sousse, Tunisia.
International journal of obesity (2005) (Impact Factor: 5.22). 03/2010; 34(6):1078-85. DOI: 10.1038/ijo.2010.22
Source: PubMed

ABSTRACT The specific objective of this investigation was to determine whether bronchopulmonary responsiveness (BPR) to methacholine (MCH) was associated with the body mass index (BMI) of Tunisian women.
In all, 160 healthy nonsmoker women (52 lean, 45 overweight and 63 obese) were recruited and examined in the Clinical Laboratory of Physiology located in the Medical School of Sousse. The average ages (+/-s.e.) of the three categories of lean, overweight and obese subjects were 27.7+/-1.1, 33.2+/-1.7 and 37.5+/-1.3 years, respectively. Their corresponding mean BMIs (+/-s.e.) were 21.9+/-0.3, 27.7+/-0.2 and 36.5+/-0.8 kg m(-2), respectively.
Before their inclusion into the study, subjects were screened for their lung status by measuring their pulmonary function testing parameters using a whole body plethysmograph. BPR was assessed, using a cumulative concentration response curve technique, by measuring with a spirometer the decrease in forced expiratory volume in 1 s (FEV(1)) in response to a cumulative dose of MCH.
After adjusting for age, significant differences in both FEV(1) and forced vital capacity (VC) were found between the obese and lean groups (P<0.01), as well as between the obese and overweight groups (P<0.01). In addition, forced expiratory flow between 25 and 75% of VC was significantly different between the obese and lean groups (P<0.001), as well as between the lean and overweight groups (P=0.015). The mean maximum fall of FEV(1) in response to MCH challenge was significantly higher for the obese group (12.0%) than for the overweight (9.8%) or the lean (6.6%) group (P<0.01). Furthermore, the efficacy of the MCH agonist promoting the maximal response (E(max)) and its potency or effective dose producing 50% of the maximal response (ED(50)) were both associated with BMI (the higher the BMI, the higher the E(max) and the lower the ED(50)).
Our data clearly show that obesity affects pulmonary function performance in Tunisian women by potentially promoting their bronchial hyperreactivity as suggested by the significant correlation between their BMI and the efficacy of the MCH, as well as its potency.

0 Bookmarks
 · 
65 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Obesity is associated with premature death and increases the risk of a number of diseases. It is also well documented that and it may affect pulmonary mechanics and exercise capacity; however little is known for walking ability and pulmonary mechanics in young obese females. The purpose of this study was to assess exercise tolerance and pulmonary mechanics in young females with obesity. Ten obese females (BMI: 38.5±4.4 Kg/m2) and 10 controls (BMI: 21.4±1.8 Kg/m2), aged 18-25 years, performed spirometry and 6 minute walk test (6MWT) according to American Thoracic Society recommendations. All participants were non-smokers and they had the same low levels of physical activity as demonstrated by the IPAQ-Gr questionnaire. Females with obesity presented lower FVC (3.1±0.2L vs 3.5±0.2L, p<.01); ERV (1.2±0.03L vs 1.3±0.01L, p<.05) and VC (3.1±0.5 vs 3.7±0.1L, p<.05) They also covered significantly smaller walking distance compared to the control group (562 m vs 649 respectively, p<.001). The obese group had higher heart rate, systolic and diastolic blood pressure after the 6MWT (p<.01) when compared to the control group. Our first set of data suggest that obesity impairs young females’ exercise capacity and pulmonary mechanics, decreasing their FVC, VC and ERV. This aspect is important due to the currently increased prevalence of obesity in young people.
    Physiotherapy Issues 2010:6(3):89-100. 09/2010; 6(3):89-100.
  • [Show abstract] [Hide abstract]
    ABSTRACT: 2010:6(3):89-100 ΠΕΡΙΛΗΨΗ Η παχυσαρκία αποτελεί υψηλό πα-ράγοντα κινδύνου νοσηρότητας και θνητότητας στον παγκόσμιο πλη-θυσμό. Στο αναπνευστικό σύστημα η παχυσαρκία ευθύνεται για μετα-βολές στις μηχανικές ιδιότητες του θώρακα και των πνευμόνων επηρε-άζοντας τη διατασιμότητά τους και μεταβάλλοντας τους πνευμονικούς όγκους. Παρότι η παχυσαρκία επη-ρεάζει το μυοσκελετικό και καρδιαγ-γειακό σύστημα με άμεσες επιπτώ-σεις στην ικανότητα για βάδιση, δεν υπάρχουν στη βιβλιογραφία επαρκή στοιχεία σε νεαρές ηλικίες. Σκοπός της πρόδρομης αυτής μελέτης ήταν η αξιολόγηση της αναπνευστικής λειτουργίας και της ικανότητας για βάδιση σε νεαρές γυ-ναίκες με υψηλό δείκτη παχυσαρκί-ας. Συμμετείχαν 10 αδρανείς (IPAQ-Gr), μη καπνίστριες, παχύσαρκες (BMI: 38.5±4.4 Kg/m 2) γυναίκες ηλι-κίας 18-25 ετών και 10 φυσιολογικού βάρους (BMI: 21.4±1.8 Kg/m 2), ως ομάδα ελέγχου. Όλες υποβλήθηκαν σε σπιρομετρικό έλεγχο και στην εξάλεπτη δοκιμασία βάδισης (6ΔΒ) σύμφωνα με τις οδηγίες της Αμερι-κανικής Εταιρείας Θώρακος. Βρέθηκαν σημαντικά χαμη-λότερες τιμές στους δείκτες της πνευμονικής λειτουργίας (FVC: 3.1±0.2L έναντι 3.5±0.2L, p<.01; ERV: 1.2±0.03L έναντι 1.3±0.01L, p<.05; VC: 3.1±0.5 έναντι 3.7±0.1L, p<.05) και στη συνολικά διανυόμενη απόσταση κατά την 6λεπτη δοκιμα-σία (562±32 έναντι 649±41 μέτρα, p<.001) για τις παχύσαρκες γυναί-κες. Επίσης, η καρδιακή συχνότητα και η αρτηριακή πίεση ήταν σημα-ντικά (p<.01) αυξημένες μετά τη βάδιση. Τα πρόδρομα αυτά στοιχεία υποδηλώνουν την πρώιμη επίδραση της παχυσαρκίας στην αναπνευστι-κή λειτουργία και στην ικανότητα για βάδιση νεαρών γυναικών.